Abstract:The aim of the present study was to find a way of prepare silybin–phospholipid complex to make oral bioavailability of silybin increase and to study its physicochemical properties and to compare the pharmacokinetic characteristics and bioavailability after oral administration of silybin–phospholipid complex and silybin-N-methylglucamine in rats. Using ethanol as a reaction medium, silybin and phospholipids were resolved into the medium, after the organic solvent was removed under vacuum condition, silybin–phospholipid complex was formed. The new complex's physicochemical properties including scanning electron microscopy (SEM), transmission electron microscopy (TEM), differential scanning calorimetry (DSC), solubility, dissolution, etc., were tested. The concentrations of silybin after oral administration of silybin–phospholipid complex and silybin-N-methylglucamine at different time in rats were determined by RP-HPLC. The pharmacokinetic parameters were computed by software program 3p97. Our data showed that silybin and phospholipids in the silybin–phospholipid complex were combined by non-covalent-bond, not forming a new compound and the solubility of silybin–phospholipid complex in water and in n-octanol was effectively enhanced. We found that mean plasma concentration–time curve of silybin after oral administration of silybin–phospholipid complex and silybin-N-methylglucamine in rats was both in accordance with open single-compartment model with first-order absorption. Pharmacokinetic parameters of silybin in rats were Tmax 10 and 5 min; Cmax 126.72 and 104.29 ng ml−1; AUC0–∞ 1020.33 and 235.81 ng ml−1 h, respectively. The bioavailability of silybin in rats was increased remarkably after oral administration of silybin–phospholipid complex comparing to silybin-N-methylglucamine. This was mainly due to an impressive improvement of the lipophilic property of silybin–phospholipid complex and improvement of the biological effect of silybin.

Nanostructured Lipid Carriers for Parenteral Delivery of Silybin: Biodistribution and Pharmacokinetic Studies.

Binary lipids-based nanostructured lipid carriers for improved oral bioavailability of silymarin.

[Study on the Preparation and Bio-Distribution of Silybin Lipid Nanospheres].

Preparation and Characterization of Silybin-Loaded Nanostructured Lipid Carriers

The Pharmacokinetics and Liver-Targeting Evaluation of Silybin Liposomes Mediated by the NTCP/OCTN2 Dual Receptors

Preparation of Silybin Loaded Nano-Micelles and Pharmacokinetic Evaluation in Mice

<i>In vitro</i>and<i>in vivo</i>evaluation of silybin nanosuspensions for oral and intravenous delivery

In vivo evaluation of silybin nanosuspensions targeting liver.

Phytosome-nanosuspensions for silybin-phospholipid complex with increased bioavailability and hepatoprotection efficacy

Silybin Meglumine-Stabilized Nanosuspension Enhances the Therapeutic Efficacy of Silybin Against Hepatic Fibrosis

In vivo fate of lipid-silybin conjugate nanoparticles: Implications on enhanced oral bioavailability.

The Preparation of Silybin–phospholipid Complex and the Study on Its Pharmacokinetics in Rats

Nanostructured calcium phosphate carriers for deliver of poor water-soluble drug silybin

Nanocrystal Formulation to Enhance Oral Absorption of Silybin: Preparation, In Vitro Evaluations, and Pharmacokinetic Evaluations in Rats and Healthy Human Subjects

Silymarin-Loaded Nanoparticles Based on Stearic Acid-Modified Bletilla striata Polysaccharide for Hepatic Targeting

Preclinical Validation of Silibinin/albumin Nanoparticles As an Applicable System Against Acute Liver Injury.

Preparation of Silybin Oral Submicron Emulsion and Its Pharmacokinetics in Rats

Solid Lipid Nanoparticles and Chitosan-coated Solid Lipid Nanoparticles as Promising Tool for Silybin Delivery: Formulation, Characterization, and In vitro Evaluation

Self-assembly and characterization of Pluronic P105 micelles for liver-targeted delivery of silybin.

In Vivo Fate of Biomimetic Mixed Micelles As Nanocarriers for Bioavailability Enhancement of Lipid-Drug Conjugates.

Studies on Preparation of Silybin Nanosuspension & Its Pharmacokinetics in Rats